Smile Doctors: The Largest Orthodontics-Focused DSO

Most dental support organizations chase scale across general dentistry, where the patient pool is widest. Smile Doctors did the opposite — it picked one specialty, orthodontics, and built the largest support platform in the country inside that single lane. For an investor sizing up the dental roll-up landscape, that focus is the whole thesis: a company only seventh-largest among dental support organizations overall, yet the undisputed number one in its specialty. It is a different bet than full-spectrum platforms like Heartland Dental or Aspen Dental.

This profile is an independent assessment based on company disclosures, private-equity sponsor materials, lender filings, and third-party industry data. Where the numbers come straight from Smile Doctors, we say so; where they come from outside estimators, we flag the hedge.

Overview

Smile Doctors LLC is an orthodontics-focused dental support organization — the company prefers the term "orthodontic support organization," or OSO — headquartered in Dallas, Texas, and founded in 2015.¹ It describes itself, consistently across years of communications, as "the largest ortho-focused dental support organization in the U.S." and "the fastest-growing network of leading orthodontists."¹

The business is a classic specialty DSO. Smile Doctors does not practice orthodontics. Instead, it provides non-clinical support — HR, marketing, accounting and finance, revenue cycle management, supply chain, legal, IT, and operations — to affiliated, orthodontist-owned practices.¹ The doctors keep clinical autonomy and own their professional entities (the structure that keeps the model compliant with state corporate-practice-of-dentistry laws); Smile Doctors captures value through management and service arrangements tied to practice performance, plus scale economies on purchasing and technology.

What distinguishes Smile Doctors from the general-dentistry consolidators is the specialty itself. Orthodontics runs on long treatment arcs — an 18-to-24-month braces or aligner case — heavy diagnostic imaging, and a recurring patient-communication cadence that a general dental office never has to manage.² That gives the platform a narrower but deeper footprint, shaping everything from the technology stack to how a practice's economics are modeled. The company also leans hard on an orthodontist-ownership identity, branding itself "orthodontists who invest in orthodontists" and noting that its founding doctors remain at the helm.³

Company Snapshot

• Founded: 2015, by orthodontists including co-founder and Chief Clinical Officer Dr. Scott Law.¹ Some industry profiles also credit Drs. Dana Fender and Greg Goggans among the founders.⁴
• Headquarters: Dallas, Texas. Earlier company history and some data aggregators reference an Austin-area base (Georgetown, Texas) from its first growth phase.¹
• CEO: John (J.) Hedrick.¹
• Model: Orthodontic support organization — non-clinical business support to affiliated, orthodontist-owned practices.
• Affiliated locations: "More than 580" as of the company's 2025 year-end wrap (see Footprint Analysis).¹
• States: 36, per the most recent company copy.¹
• Current owners: Co-controlled by Linden Capital Partners and Thomas H. Lee Partners (THL), with affiliated orthodontists holding a significant minority stake (see Growth History).⁵
• Estimated revenue: A third-party analysis reported "north of $1 billion" in 2024 — not company-confirmed; directional only.⁴

Footprint Analysis

Smile Doctors' scale is one of the cleaner stories in the DSO field, because the company narrates its own growth in dated press releases — but an investor should still mind the unit being counted.

The most current company figure is "more than 580 locations across 36 states," stated in a February 2026 release wrapping up 2025, a year in which it says it added more than 100 new locations and marked its tenth anniversary.¹

The trajectory behind that number shows how fast the platform compounded: "more than 295 locations in 25 states" at the THL investment in January 2022; "more than 400" across 28 states by July 2023; "more than 460 locations across 32 states" closing out 2024; then a jump to "more than 550 locations across 36 states" in Q1 2025; and "more than 580" by February 2026.¹

The step-change in early 2025 was the acquisition of myOrthos, which the company says added roughly 70 affiliated locations across 13 states and four new states in one move.¹ The rest of the growth came from individual practice affiliations and de novo (brand-new) office openings.

One caveat to hold onto: Smile Doctors uses "locations," "affiliated practices," and "clinics" more or less interchangeably, so the 580+ figure is best read as supported offices rather than a precise count of distinct practice entities or doctors. Third-party doctor counts (one 2024 analysis referenced "650+ doctors") are estimates, not disclosures.⁴ The state count (36) is the most stable metric in the company's reporting.

Growth History

Smile Doctors has grown through the standard specialty-roll-up playbook — affiliations plus de novo openings — and through a succession of private-equity sponsors an investor should study carefully, because the ownership record has a few moving parts. The documented sequence runs:

• Sheridan Capital Partners — a lower-middle-market sponsor, lists a November 2015 investment date and appears to have been the first institutional backer, helping build the initial platform alongside the founding orthodontists (with the Chicago-based Thurston Group involved in the company's formation).⁵
• Linden Capital Partners — a Chicago healthcare-focused private-equity firm, made an investment in 2017 that, per the available record, made it the majority owner, with Sheridan moving to a minority position.⁵ Under Linden, the network roughly doubled — from about 150 locations to more than 295 by early 2022.⁵
• Thomas H. Lee Partners (THL) — on January 5, 2022, made a strategic investment, joining Linden in what all three parties' announcements describe as an "equal partnership," with affiliated orthodontists retaining "a significant ownership stake."⁵ Crucially, THL did not replace Linden; it joined as a co-sponsor.

That co-sponsorship is the key structural fact. As of 2025–2026, the most defensible reading of the public record is that Linden Capital Partners and Thomas H. Lee Partners jointly control Smile Doctors, alongside meaningful doctor ownership. A March 2026 Bloomberg report on a potential debt refinancing still described the company as "THL- and Linden-backed," and neither sponsor's portfolio materials indicate an exit.⁵ Trade press has reported that Linden was "prepping" or exploring a sale of Smile Doctors, but no completed sale to a new control sponsor has been announced, so those reports should be read as evidence of market-testing, not a change of ownership.⁵ As with any private company, the exact cap table and equity percentages are not public, and we hedge accordingly.

On the financing side, the platform carries substantial leverage. A Blackstone-led private-credit package has been described as a roughly $1.3 billion first-lien term loan plus a $138 million delayed-draw tranche, with Blackstone's publicly filed holdings showing a loan to Smile Doctors maturing in December 2028.⁵ In July 2023, the company announced a capital raise of "over $550 million," funded by doctors along with "several large domestic and international healthcare investors" it did not name, for affiliation growth, technology, and staffing.⁵ By early 2026, it was reportedly weighing a refinancing of roughly $2 billion of debt to lower borrowing costs — opportunistic, not forced, since the existing debt does not mature until 2028.⁵ For an investor, that leverage and the layered, lender-heavy capital structure are the central risk flags; no source explicitly characterizes any of these financings as a dividend recapitalization, so we do not assert one.

Business Model

Smile Doctors earns money the way specialty DSOs do: by charging affiliated practices for the business support it provides, with the arrangement structured to capture a share of the efficiency it creates. The company does not bill patients for clinical care — the orthodontist-owned professional entities do that — and it derives revenue from its contractual support arrangements with them.

The distinguishing feature is the doctor-ownership and equity orientation. Smile Doctors markets itself to prospective affiliates as "orthodontists who invest in orthodontists," emphasizing a "freedom within a framework" approach — "we support doctors, not manage them."³ Its partner pitch centers on an explicit equity model and a structured "Pathway to Partner" track from associate to ownership.³ This competes directly with the doctor-partnership narratives used by platforms like MB2 Dental and PDS Health, and it is the company's primary recruiting lever in a specialty where orthodontists have historically prized autonomy.

A second model wrinkle is the Joint Venture Model, introduced in 2023. It lets established, doctor-led brands expand into new markets while keeping a degree of local ownership and identity, and includes "tuck-in" acquisitions in which a doctor partner and Smile Doctors jointly buy a nearby location and rebrand it under the partner's brand.³ Unlike single-banner consolidators, Smile Doctors will preserve a partner's local brand when that serves the affiliation.

On revenue, the only available figures are third-party estimates. A business-strategy analysis pegged 2024 revenue at "north of $1 billion" and floated a 15–20% share target of the specialized orthodontic DSO market; both are outside estimates, not disclosures, and should be read as directional only.⁴ No precise, company-reported corporate or management-fee revenue figure is public, and an investor should resist treating patient billings (what the practices collect) as a proxy for Smile Doctors' own management-level revenue — they are different lines.

Technology & Software Ecosystem

Public detail on Smile Doctors' internal technology stack is thinner than the company's marketing suggests, but the sourced picture is of an OSO built around the dominant clear-aligner ecosystem plus a couple of proprietary patient-facing tools.

The two named in-house programs are Smile Doctors Anywhere — a remote-care app for scheduling, virtual check-ups, and tracking treatment progress — and the Smile Express workflow, an at-home clear-aligner option for adults.² On treatment, the company offers comprehensive Invisalign alongside Smile Express, and has described itself as "the largest network of Diamond Plus Invisalign providers" — Diamond Plus being Align Technology's top provider tier.⁵ That status strongly implies heavy reliance on the Align ecosystem (iTero scanners, ClinCheck treatment planning, Invisalign virtual care) as the clinical and diagnostic backbone across hundreds of offices.

A third-party growth analysis has claimed the company invested in 2024 to build proprietary practice-management software with embedded AI for scheduling and revenue-cycle tasks.⁴ That claim comes from an outside analyst overlay rather than detailed company documentation, so it should be read as illustrative rather than confirmed. The broader point holds: a specialty DSO faces a heavier imaging and longer treatment-planning workload than general dentistry, which makes a standardized, scanner-centric digital workflow a natural place to concentrate technology spend.² As with most private DSOs, the stack should be treated as illustrative, not exhaustive.

Competitive Landscape

Smile Doctors occupies an unusual spot: a mid-tier finisher in the all-DSO race, but the clear leader of its specialty. Using a 2026 ranking that draws on Becker's Dental Review's November 2025 data, the rough hierarchy of the largest US DSOs by supported-practice count is:⁴

• Heartland Dental — more than 1,900 offices across 39 states and DC; owned by KKR. The scale leader by a wide margin.
• Aspen Dental (The Aspen Group) — more than 1,100 offices nationwide; backed by Leonard Green & Partners and Ares Management.
• PDS Health (formerly Pacific Dental Services) — around 1,000 offices; dentist-owned at the platform level.
• MB2 Dental — more than 800 offices; backed by Warburg Pincus and Charlesbank, with a doctor-partnership narrative.
• Smile Brands — around 600 offices under 75+ brands; Gryphon Investors.
• Sonrava Health — roughly 600 offices (Western Dental, Brident); PE-backed.
• Smile Doctors — more than 580 locations across 36 states; Linden + THL.

That places Smile Doctors at roughly seventh among all US DSOs by location count — but the comparison misleads without context, because every platform above it is a general-dentistry or multi-specialty operator. Among orthodontics-focused DSOs, Smile Doctors stands alone at the top; Becker's, Aspen Dental's industry list, and other trackers consistently name it the largest ortho-focused DSO in the country.⁴ Its real competitive set is not Heartland or Aspen but independent orthodontists, the in-house ortho departments of the multi-specialty DSOs, and direct-to-consumer aligner challengers. For context on the consolidation wave it is riding: the five largest DSOs support more than 5,600 practices combined, and the great majority of scaled DSOs are private-equity-backed.⁴

Market Position

Smile Doctors' position is best understood as a category-defining specialist rather than a scale generalist. Its strengths are specific: undisputed leadership of the orthodontic-DSO niche, a fast and well-documented growth record (from ~295 to 580+ locations in four years), a genuine doctor-equity and "Pathway to Partner" story that gives it a recruiting edge in an autonomy-prizing specialty, and a flexible joint-venture model that lets it absorb practices without erasing their local brands. The myOrthos acquisition showed it can grow inorganically in large bites when the opportunity appears.

The pressures are equally specific. Specialty concentration cuts both ways: Smile Doctors has no general-dentistry revenue to cushion a downturn in orthodontic demand, which is discretionary, financing-sensitive, and exposed to direct-to-consumer aligner competition. Its leverage is substantial — a roughly $1.3 billion-plus credit package and a contemplated ~$2 billion refinancing — leaving less margin for error in a higher-rate environment. And the standard private-equity endgame looms: with Linden in since 2017 and THL since 2022, an eventual sponsor exit is the most likely next chapter, and reported sale-process chatter suggests the sponsors have at least tested the market. For an investor, Smile Doctors reads as a focused, fast-growing platform whose value hinges on the durability of orthodontic demand and the orderly handling of its leverage and eventual exit.

TMR Take: For operators (orthodontists weighing affiliation): Smile Doctors offers a real equity path ("Pathway to Partner") and a joint-venture option that can preserve your local brand rather than fold it into a national one — attractive if you value ownership upside and autonomy. Diligence the support-fee structure and how much the platform's leverage shapes pressure on production and case-volume targets. For vendors: This is a large, specialty-concentrated buyer with an unusually standardized clinical profile — heavy imaging, long aligner and braces cases, and a deep Align/Invisalign relationship (largest Diamond Plus provider). Procurement decisions are made at the support-org level, so selling in means understanding how standardized the workflow already is across 580+ locations. For investors: Smile Doctors is the largest orthodontics-focused DSO in the US (~580+ locations, 36 states) and roughly seventh among all DSOs by location count. The watch items are leverage (a ~$1.3B-plus credit package, a contemplated ~$2B refinancing) and ownership — Linden Capital Partners and Thomas H. Lee Partners co-control as of early 2026; reported sale-process talk has not produced a documented new owner. Treat the ~$1B-plus revenue figure as an unverified third-party estimate, and don't conflate patient billings with management-level revenue.

Sources

1. Smile Doctors — company website, About page, and press releases (BusinessWire / PRNewswire, 2022–2026).

2. Industry analysis of specialty / orthodontic DSO operations and technology.

3. Smile Doctors Partners — affiliation and partner-program materials.

4. Industry DSO rankings and market analysis — Becker's Dental Review and third-party estimators.

5. Ownership and financing sources — Linden Capital Partners and Thomas H. Lee Partners disclosures, Sheridan Capital portfolio, lender filings, and deal coverage.